Category: Finance
-
Pharmas, Foundations, Agencies Partner on Tropical Diseases
In London yesterday, the Bill & Melinda Gates Foundation, 13 pharmaceutical companies, three governments, the World Bank and global health agencies announced a new plan to eliminate or control 10 neglected tropical diseases (NTDs) by 2020. The effort announced at an event at the Royal College of Physicians is aimed at 1.4 billion people living…
-
Venture Investment for European Companies Drops in 2011
Venture capital declined 14 percent and number of deals dropped 19 percent for European companies in 2011 compared to 2010, with €4.4 billion ($US 5.8 billion) going into 1,012 deals. Industries based on scientific discoveries were among those suffering double-digit percentage declines from the previous year. Dow Jones VentureSource that compiled the data says it…
-
Knee Replacement Maker Lands $89M Series E Financing
ConforMIS Inc. in Burlington, Massachusetts, a developer of customized knee-replacement implant technology, has raised $89 million in a series E round of funding, the fifth investment cycle after start up. The privately held company says the investments were made by private equity funds, led by AGC Equity Partners and Axel Johnson Inc., along with government…
-
VC Company, Harvard Start Seed-Stage Fund
The Experiment Fund, a joint venture of Harvard University’s engineering school and venture capital company New Enterprise Associates (NEA), opened today in Cambridge, Massachusetts. The fund plans to support technology-based student start-ups in Cambridge and companies begun elsewhere by former students. The venture expects to support companies working in information technologies, health care, and energy.…
-
Columbia Joins Coulter Biomedical Engineering Partnership
Columbia University in New York and the Wallace H. Coulter Foundation in Miami will establish the Columbia-Coulter Translational Research Partnership, part of a network of biomedical engineering and translational research institutions in the U.S. The program is expected devote $5 million in funding over five years, with two-thirds of the funds from the Coulter Foundation,…
-
$250K Challenge Seeks Post-Hospital Care Ideas
Janssen Healthcare Innovation, a unit of pharmaceutical company Johnson & Johnson in San Diego, is offering a challenge with a total of $250,000 in awards for technology solutions to improve the care for patients discharged from the hospital. The Janssen Connected Care Challenge was announced today by Kimberly Park, a Janssen Healthcare Innovation partner, at the…
-
Celgene to Acquire Avila Therapeutics
The pharmaceutical company Celgene Corp. in Summit, New Jersey says it will acquire Avila Therapeutics, a biotechnology company in Bedford, Massachusetts. Celgene discovers and commercializes therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. Avila develops covalent drugs, those that bind to and inhibit disease-causing proteins. Under the agreement, Celgene…
-
NSF Supporting Research to Reduce Fertilizer Use in Maize
Researchers at three universities, the Donald Danforth Plant Science Center, and USDA’s Agricultural Research Service have received a $1.3 million grant from National Science Foundation for research on reducing the amount of fertilizer to grow maize. The three-year project is led by the ARS’s Ivan Baxter, who also serves on the Danforth Center’s faculty in…
-
Grant to Fund New Program Logic for Flight Data Integration
A grant from the U.S. Air Force to Rensselaer Polytechnic Institute in Troy, New York will fund development of computer logic to help create safer and more efficient flight technology. The $100,00 grant was awarded to computer scientist Carlos Varela of Rensselaer’s Data Science Research Center, who is also a licensed pilot (pictured right). Varela’s…
-
Dutch Biotech Raises $30M for Rare Disease Therapies
Prosensa, a biopharmaceutical company in Leiden, the Netherlands, says it has raised €23 million ($30 million) in new equity financing. The company develops therapeutics using ribonucleic acid (RNA) modulation to address rare diseases, including Duchenne muscular dystrophy, myotonic dystrophy, and Huntington’s disease. The funding round is led by New Enterprise Associates in Menlo Park, California,…